NRT Smoking Cessation Aids in Latvia
Euromonitor International's NRT Smoking Cessation Aids in Latvia market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 27 | Publication date: Mar 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
NRT gum; NRT inhalators; NRT lozenges; NRT patches; Other NRT
Table of contents
NRT SMOKING CESSATION AIDS IN LATVIA : MARKET INSIGHT
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR INDICATORS
Table 1 Number of Smokers by Gender 2003-2008
SECTOR DATA
Table 2 Sales of Smoking Cessation Aids by Subsector: Value 2003-2008
Table 3 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2003-2008
Table 4 Smoking Cessation Aids Company Shares by Value 2004-2008
Table 5 Smoking Cessation Aids Brand Shares by Value 2005-2008
Table 6 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2008-2013
Table 7 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2008-2013
LOCAL COMPANY PROFILES - LATVIA
GRINDEKS AS - OTC HEALTHCARE - LATVIA
STRATEGIC DIRECTION
KEY FACTS
Summary 1 Summary - Grindeks AS: Key Facts
Summary 2 Summary - Grindeks AS: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 3 Summary - Grindeks AS: Competitive Position 2008
OLAINFARM AS - OTC HEALTHCARE - LATVIA
STRATEGIC DIRECTION
KEY FACTS
Summary 4 Summary - Olainfarm AS: Key Facts
Summary 5 Summary - Olainfarm AS: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 6 Summary - Olainfarm AS: Competitive Position 2008
RIGAS FARMACEITISKA FABRIKA A/S - OTC HEALTHCARE - LATVIA
STRATEGIC DIRECTION
KEY FACTS
Summary 7 Summary - Rigas Farmaceitiska Fabrika AS: Key Facts
Summary 8 Summary - Rigas Farmaceitiska Fabrika AS: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
OTC HEALTHCARE IN LATVIA
EXECUTIVE SUMMARY
Popularity of self-medication continues to grow
Sales are increasing but growth rates are slowing down
Multinationals dominate in a highly competitive environment
Chemists/pharmacies the main distribution channel
OTC sales will continue to rise
MARKET INDICATORS
Table 8 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 9 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 10 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 11 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 12 OTC Healthcare Company Shares by Value 2004-2008
Table 13 OTC Healthcare Brand Shares by Value 2005-2008
Table 14 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 15 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 16 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 17 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
Generics
Switches
Summary 9 Summary - OTC Healthcare Switches 2005-2008
DEFINITIONS
Summary 10 Summary - Research Sources